Synapse Open Synapse
Biology

STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug

STAT News · · 1 min read

Dutch antitrust regulators are investigating allegations that Biogen may have abused its dominant position in the market for MS treatments and associated blood tests.

Latest from STAT News